Drama Desk Awards Signal Shift in Tony Awards Competitive Landscape Global Ship Lease Reports First Quarter 2026 Results Management Discusses Market Conditions and Fleet Utilization Borosil Glass Works Surges Over 200 in a Year Key Drivers Behind the Rally UK Student Loan Inquiry Garners Over 52000 Grievances Highlighting Mounting Debt Concerns Disneys Star Wars The Mandalorian and Grogu Opens with Lowest Thursday Previews in Franchise History Nvidias Blockbuster Quarter Reveals 200 Billion Opportunity and Edge Computing Shift as China Market Conceded PASG Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Response B Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Gold Price Tailwinds DMRC Q1 2026 Earnings EPS Surpasses Estimates with 5267 Beat BTCS Q1 2026 Earnings EPS Miss and Revenue Void Weigh on Shares SPG Q1 2026 Earnings Slight EPS Miss Amid Stable Retail Fundamentals Verisk Analytics VRSK Holds Steady Near Resistance A Technical Assessment Stabilis Solutions SLNG Slips 276 as Stock Nears Key Support Zone HubSpot HUBS Edges Higher as Investors Eye Key Resistance Level QXO Inc QXO Edges Higher Approaches Key Resistance at 1856 Chime Financial Inc CHYM Nears Support as Shares Dip 083 Anika Therapeutics ANIK Holds Steady Near Support as Slight Decline Persists Asian Paints Reports Strong Q4 Rebound Declares 2750 Dividend for FY26 QUALCOMM Q1 2026 Earnings EPS Beats Estimates Driven by Strong Chip Demand Intuitive Surgical Announces 100 Upgrades to da Vinci 5 Robot Rollout Starting June RIME Surges 826 Algorhythm Holdings Tests Key Resistance at 078 Sterling Infrastructure STRL Holds Steady as Key Technical Levels Come into Focus Core Natural Resources Inc CNR Surges 4 as Momentum Builds Toward Key Resistance Hour Loop Inc HOUR Edges Higher Navigating Support and Resistance Levels Northfield Bancorp NFBK Holds Ground Near 1422 Support and Resistance Levels in Focus CocaCola Consolidated COKE Holds Near Resistance Amid Modest Decline LIC Stake Sale Government May Launch 1 Billion OFS Next Month Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development Chemours CC Holds Steady Near Support as Consolidation Continues